Literature DB >> 7747304

Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study.

L E Duncan1, A M Elliott, R J Hayes, S K Hira, G Tembo, G T Mumba, S H Ebrahim, M Quigley, J O Pobee, K P McAdam.   

Abstract

A cross-sectional study to estimate the prevalence of latent tuberculosis (TB) in a group of Zambians at high risk of human immunodeficiency virus type 1 (HIV-1) infection and to examine the effect of HIV-1 infection on the tuberculin response was conducted in the University Teaching Hospital in Lusaka, Zambia during July to September 1990. Patients were selected from those presenting to the out-patient clinic for first referral with either sexually transmitted or skin disease. 268 adults were included in the study; 158 (59%; 95% confidence interval [CI] = 53-65%) were HIV-1 antibody positive. Of 82 HIV-1 negative participants who returned for Mantoux skin test reading, 51 (62%; 95% CI = 57-67%) had a positive test reaction (diameter > or = 10 mm) after receiving 2 units of RT-23 tuberculin. Of 106 HIV-1 positive participants who returned, only 32 (30%; 95% CI = 26-34%) had a diameter > or = 10 mm. Nine (28%) of the HIV-1 positive and Mantoux positive participants had large reactions > or = 30 mm, compared to 4 (8%) of the HIV-1 negative, Mantoux positive participants (P = 0.03). Results in the HIV-1 negative group indicated a prevalence of latent TB of 62% in this population. HIV-1 infection was associated with a much higher frequency of negative response to tuberculin and with a few large skin test responses. Thus, in populations where HIV seropositivity is high, Mantoux skin tests cannot be used to assess those with latent TB who might benefit from chemoprophylaxis.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Dermatological Effects; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hiv Infections; Hiv Serodiagnosis; Infections; Laboratory Examinations And Diagnoses; Physiology; Reproductive Tract Infections; Research Report; Sexually Transmitted Diseases; Tuberculosis; Viral Diseases; Zambia

Mesh:

Year:  1995        PMID: 7747304     DOI: 10.1016/0035-9203(95)90649-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Significance of Tuberculin Testing in HIV Infection: An Indian Perspective.

Authors:  Mps Sawhney; Y K Sharma
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.

Authors:  Annie F Luetkemeyer; Edwin D Charlebois; Laura L Flores; David R Bangsberg; Steven G Deeks; Jeffrey N Martin; Diane V Havlir
Journal:  Am J Respir Crit Care Med       Date:  2007-01-11       Impact factor: 21.405

3.  Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.

Authors:  Kwame Shanaube; James Hargreaves; Katherine Fielding; Ab Schaap; Katherine-Anne Lawrence; Bernadette Hensen; Charalambos Sismanidis; Angela Menezes; Nulda Beyers; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

4.  Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays.

Authors:  Naasha J Talati; Esteban Gonzalez-Diaz; Charles Mutemba; Joyanna Wendt; William Kilembe; Lawrence Mwananyanda; Elwyn Chomba; Susan Allen; Carlos del Rio; Henry M Blumberg
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

Review 5.  The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review.

Authors:  Andrew D Kerkhoff; Ankur Gupta; Taraz Samandari; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2013-07-08       Impact factor: 3.090

6.  Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.

Authors:  Basel Karo; Gérard Krause; Stefanie Castell; Christian Kollan; Osamah Hamouda; Walter Haas
Journal:  BMC Infect Dis       Date:  2017-07-25       Impact factor: 3.090

7.  Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.

Authors:  T Oni; J Patel; H P Gideon; R Seldon; K Wood; Y Hlombe; K A Wilkinson; M X Rangaka; M Mendelson; R J Wilkinson
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

8.  Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.

Authors:  Clíona Ní Cheallaigh; Ian Fitzgerald; Jacinta Grace; Gurmit Jagjit Singh; Nahla El-Eraki; Noel Gibbons; Joseph Keane; Thomas R Rogers; Susan Clarke; Colm Bergin
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Diagnosing latent tuberculosis infection in the HIV era.

Authors:  Philippe H Lagrange; Jean Louis Herrmann
Journal:  Open Respir Med J       Date:  2008-05-23

10.  The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.

Authors:  Edward Raby; Maureen Moyo; Akash Devendra; Joseph Banda; Petra De Haas; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.